NCT06840691View on ClinicalTrials.gov

A Bioequivalence Study of Two Different Processes of PEG-rhGH Preparations

PHASE1Not yet recruitingINTERVENTIONAL
Enrollment

87

Participants

Timeline

Start Date

May 31, 2025

Primary Completion Date

May 31, 2025

Study Completion Date

September 30, 2025

Conditions
Pediatric Growth Hormone Deficiency (PGHD)
Interventions
DRUG

PEG-rhGH with new preparation (T)

A single subcutaneous injection of PEG-rhGH with new preparation

DRUG

PEG-rhGH with present preparation (T)

A single subcutaneous injection of PEG-rhGH with present preparation

Trial Locations (1)

610000

Chengdu Xinhua Hospital, Chengdu

All Listed Sponsors
lead

Changchun GeneScience Pharmaceutical Co., Ltd.

INDUSTRY